Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Understanding the financial goals you should have at 55 is vital for retirement planning. Explore key objectives to focus on for success.
27,702 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Microsoft has faced a sharp pullback as AI spending and cloud dynamics shift. This article weighs the risks and oppor...
JPMorgan Chase CEO Jamie Dimon warned that U.S. defense procurement has shifted toward European-style bureaucracy, po...
With Apple set to celebrate 50 years, Steve Wozniak’s skepticism about AI highlights a broader investor caution as ex...
Rocket Lab faces a pivotal Q1 print this evening as analysts weigh Neutron timing against a record backlog. Guidance ...
A May 2026 debate over private listings puts Greg Hague of 72SOLD at the center, arguing that private channels can sa...
Adobe stock faces a challenging year but shows signs of a turnaround as AI monetization accelerates and enterprise de...
Bitcoin slips below the $80,000 level, dragging ripple (xrp) and solana (sol) lower as yields rise and hedging pressu...
With winter looming, Ryanair faces higher jet fuel costs. The airline’s CFO says contingency plans are in place as fu...
Showings unveils a no-listing-fee brokerage model that relies on assisting agents and AI to speed listings, betting b...
Bank of America's Vivek Arya sees Nvidia climbing to $350 as AI-driven demand sustains a broad, structural shift in c...
FBTC holds roughly $12 billion in Bitcoin inside a grantor-trust structure, but forced annual distributions create or...